Renal Safety of Tenofovir Disoproxil Fumarate in HIV-1 Treatment-experienced Patients with Adverse Events Related to Prior NRTI Use
Santiago Moreno(Universidad El Bosque), María Luisa Álvarez(Hospital de Sant Pau), Javier Murillas, Rosario Palacios(Bellvitge University Hospital), Javier Ena(Hospital Marina Baixa), Peré Domingo(Hospital de Sant Pau), Jesús Santos(Hospital Clínico Universitario Virgen de la Victoria), Vicenç Falcó(Universitat Autònoma de Barcelona), Vicente Estrada(Instituto de Salud Carlos III)
Cited by 30
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396